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The Crosstalk between RhoC and Cdc42 during invadopodia formation 
mediated by Palladin 
 
Emilio C. Merheb 
 
ABSTRACT 
 
Cell metastasis is the main difference between malignant and benign tumors, and it is 
a main contributor to the high mortality rate of malignant cancer. Therefore, it is of 
great interest to study the pathways involved in the motility of cancer cells, which are 
regulated by the Rho family of small GTPases. This study examines the role of the 
Rho GTPases, RhoC and Cdc42 in 3D cell motility, mainly in the formation of actin 
structures termed invadopodia. RhoC was shown to play a role in both 2D and 3D cell 
motility; whereas, the action of Cdc42 is limited to 3D motility. We first established 
the formation of invadopodia through PMA stimulation. Next, our results showed that 
these invadopodia are Cdc42 dependent and that the inhibition of ROCK leads to the 
increase in invadopodia formation. It was also shown that RhoC downregulates the 
activation of Cdc42 which leads to the final conclusion that RhoC is active around the 
invadopodia structure, where it inhibits Cdc42 through the action of ROCK, allowing 
the invadopodia structure to become more concentrated and focused. Additionally, 
Palladin protein was shown to inhibit Cdc42, which may imply a crosstalk between 
palladin, RhoC and Cdc42 in invadopodia formation. 
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Chapter 1 
 
Literature Review 
 
 
1.1.  Cancer Hallmarks 
1.1.1. Cancer Overview 
Cancer is a term denoted to a group of related diseases, which involve the 
abnormal and continuous proliferation of the cells and their possible spread into 
surrounding tissues. 
Cancer cells accumulate mutations which give them common characteristics, 
such as continuous proliferation or cell division irrespective of growth signals, 
resistance to cell death or evasion of apoptosis and tumor suppressor genes, loss of 
cell cycle regulation, evolution toward metastasis through downregulating both cell-
cell and cell-matrix contacts, and induction of angiogenesis (Dalkic, et al., 2010).  
Cancerous tumors are divided into two types malignant or benign. The main 
difference between the two groups is the ability to invade.  
Malignant tumors can extend or invade into nearby tissues. Moreover, during the 
growth of these tumors, individual cancer cells can spread to different locations or 
organs using the blood or the lymph system, leading to the formation of new tumors 
far from the original tumor. 
On the other hand, benign tumors do not invade surrounding tissues. Although they 
can be large, once removed, they do not recur (Parker et al., 2003). 
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1.1.2. Differences between Cancer Cells and Normal Cells 
 
 Cancer cells have different characteristics than normal cells, mainly relating 
to their abnormal pattern of growth and potential for invasion. First, cancer cells lose 
their differentiation. This means that normal cells, unlike cancer cells, differentiate 
into specific cell types, which function differently than each other. This is a main 
reason why cancer cells continue to divide uncontrollably, unlike normal cells. 
Second, cancer cells have the ability to induce angiogenesis, as in the formation of 
blood vessels from their surroundings, providing the tumor with nutrients and oxygen 
needed for growth and proliferation (Dalkic, 2010). 
1.1.3. How Cancer Arises 
 Cancer cells arise mainly due to specific mutations affecting oncogenes and 
tumor suppressor genes. Such mutations enhance the ability of tumor cells to resist 
growth suppressors, induce angiogenesis, and increase cell motility and invasion 
(Hanahan & Weinberg, 2011).  
 These mutations can be the result of either genetic factors or environmental 
factors such as exposure to radiation, virus infections, or carcinogens such as tobacco 
smoke (American Cancer Society, 2014). 
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Fig. 1. Several mutations must occur in the cell genome to develop cancer. Mutation in normal cells 
(light gray) result in a higher proliferation rate. Mutated cells (light blue) due to their faster growth 
with respect to normal cells, may have higher rate of mutations resulting in a faster growth, when 
enough mutation is accumulated it will result in tumor formation (blue cells). More mutations has to 
take place to convert this tumor to malignant (red cells) and even to metastatic one to reach other 
organs. (Source: Jay D. Hunt, LSU Health Sciences Center) 
1.1.4. "Drivers" of Cancer 
 The three key types of genes that tend to be affected by the genetic changes 
playing a role in cancer are: proto-oncogenes, tumor suppressor genes, and DNA 
repair genes. The previously mentioned mutations can be termed “drivers” of cancer 
(Deorah, Lynch, Sibenaller & Ryken, 2006). 
 The involvement of proto-oncogenes as well as tumor suppressor genes is 
found also in normal cell growth and division. Nevertheless, an increase in the activity 
of proto-oncogenes, due to mutations, transforms them into oncogenes responsible for 
continuous abnormal proliferation of cancer cells. On the other hand, mutations 
leading to loss of activity of tumor suppressor genes result in resistance of cancer cells 
to apoptosis (Hanahan & Weinberg, 2011). 
 On a regular basis DNA repair genes have a role in correcting damaged DNA. 
Cells having mutations in these genes will accumulate other mutations elsewhere in 
their genome. Altogether, these mutations might be the origin of the cells to transform 
into cancerous growths (Hanahan & Weinberg, 2011). 
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1.2. Cell Migration and Invasion 
1.2.1. Cell Motility 
 Cell motility is central to many important physiological processes and a key 
element in the evolution of cancer cells toward metastasis (Lauffenburger & Horwitz, 
1996). Therefore, investigating cell motility leads to the possible development of new 
therapeutic approaches targeting tumor growth and metastasis.  
 Cell motion occurs towards a chemoattractant, which influences the direction 
of movement. It involves the formation of an actin-based protrusion stabilized by 
adhesion structures to the substratum. Simultaneously, the forward pull is allowed by 
actomyosin contractility and adhesions disassembly at the tail of the cell (Hanna & 
El-Sibai, 2013).  
 Cell migration leading to tumor invasion, is a complex process that starts by a 
series of intracellular signals leading to the dynamic regulation of the cytoskeleton in 
response to specific environmental cues (Condeelis et al., 2001). 
1.2.2. Cell Motility and Metastasis 
 Secondary tumors resulting from metastasis are considered the main cause of 
mortality in patients having cancer instead of the primary tumors (Goicoechea et al., 
2013). Metastasis starts at the moment when tumorous cells are no longer attached to 
their initial location, gaining the ability to move. This confers the ability to spread 
allowing the intravasation process to take place. (Parker et al., 2003). 
 Metastatic cells have the ability not only to move to but also to invade the 
surrounding extracellular matrix. This ability is dependent on the formation of 
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protrusive structures that are identified as lamellipodia, invadopodia/podosomes and 
filopodia (Wang et al., 2004). 
The binding of chemoattractants to surface receptors stimulate intracellular signaling 
pathways which regulates the formation of particular actin structures (Mykkanen et 
al., 2001). 
1.2.3. The Actin Model 
 Cells migrate in 2D or 3D depending on the surroundings and on their need. 
Cytoskeleton rearrangement is seen in all the previously mentioned structures 
irrespective of the distinct ways of locomotion used by different cells (Hall, 2009). 
 Primarily an essential shift lies in the cells transforming from the non-
polarized into the polarized state for 2D migration. The cell is able to move whenever 
the front protrudes and adheres behind the leading edge, creating focal links with the 
extracellular matrix (Parker & Sukumar, 2003). The cell’s tail will end up detaching 
and retracting. For lamellipodia and filopodia to form as described in 2D migration, 
actin cytoskeleton restructuring is required (Small, 1994). 
 Besides actin reorganization, the formation of actin – myosin complexes 
confers a contractile force which is essential for cell movement. The energy required 
for this process to occur is provided through the hydrolysis of ATP (Hall, 2009). 
Temporal and spatial polymerization and contractility must be established for optimal 
migration to take place. 
A proposed theory established that contraction takes place at the posterior end while 
polymerization occurs at the anterior end. This accounts for the saying that the 
activation of Rho is witnessed both at the anterior and posterior ends, leading to the 
observed polymerization and contraction (El-Sibai et al., 2008; Pertz et al., 2006). In 
addition to that, chemotaxis is considered another significant concept in both actin 
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dynamics and cell motility. This process was proven to play a role not only in 
invadopodia formation but also in 3D cell migration. According to John Condeelis in 
an EGF concentration gradient, invadopodia accumulates in the direction of the 
attractant (DesMarais et al., 2009). 
 Until now, four main forms of membrane protrusions were previously 
recognized, consisting of blebs, lamellipodia, filiopodia and invadopodia or 
podosomes. Both lamellipodia and filopodia contribute in onward motility; however, 
invadopodia associates with actin polymerization upon matrix-acting 
metalloproteases availability (Ridley, 2011; Bear & Gertler, 2009). 
The approved model for the formation of lamellipodium is heavily dependent on 
Arp2/3 activity. Cofilin initially plays a role in severing actin filaments, providing 
novel fast growing ends. These sites will be bound by Arp2/3 for the initiation of actin 
polymerization in addition to nucleation later on, which will lead to the generation of 
new branched filaments (Mullins et al., 1998). 
 On the other hand, formins also play a role in the nucleation of actin filaments 
without the action of the Arp2/3 complex, creating unbranched filaments. Cofilin 
severing and profilin activation are followed by the delivery of actin monomers to the 
site of polymerization (Pollard & Borisy, 2003; Ponti et al., 2004; Yang et al., 2007).  
 The formin family along with several others are the key actors in the formation 
of filopodia. The activation of actin polymerization is dependent on the recruitment 
of mDia2, Cdc42 and Cdc42 targets to the cell membrane (Breitsprecher et al., 2011). 
The polymerization of actin filaments takes place de novo or using lamellipodium as 
origin for actin. 
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 A different pathway is along Arp2/3 where Cdc42 induces WASP/Arp2/3 
actin polymerization, adding to mDia2-dependent actin polymerization (Wang et al., 
2010; Takenawa & Suetsugu, 2007). 
  
 
 
Fig. 2. 2D motility is a multistep process. First step is the formation of protrusion (1), followed by 
focal adhesion formation anchoring this protrusion (2), then the cell contracts (3) using the previously 
formed anchorage which will result in cell movement after the disassembly of the focal adhesions at 
the tail end (step 4)(Ladoux & Nicolas, 2012). 
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1.3. Rho GTPases: 
 The malignant potential of cancer cells is highly related to their migration 
ability resulting in tumor invasion and spread to distal foci. This cell motility cycle is 
controlled by the family of Rho GTPases, whose members are small GTP-binding 
proteins involved in the reorganization of the actin cytoskeleton, cell polarity, and 
signal transduction pathways. They function as molecular switches that transmit 
extracellular cues through their downstream effectors and are involved in several 
important cell mechanisms such as actin turnover, gene expression, cell cycle control, 
cell attachment, movement and invasion (Sahai et al., 2002). 
 The function of Rho GTPases is tightly regulated by three classes of proteins, 
Guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), 
and guanine nucleotide dissociation inhibitors (GDIs) (Symons et al., 2000). 
 In response to a stimulus which activates receptor tyrosine kinase, PI3-kinase 
changes PIP2 into PIP3, which recruits guanine nucleotide exchange factors (GEFs) 
to the cell membrane through their PH domain. GEFs allow Rho GTPases to switch 
from inactive cytoplasmic GDP-binding to active GTP-binding forms. GTPase-
activating proteins (GAPs) inactivate Rho GTPases by turning on their intrinsic 
GTPase activity leading to the hydrolysis of GTP to GDP. Finally, guanine-nucleotide 
dissociation inhibitors (GDIs) prevent interactions of Rho GTPases with both GEFs 
and GAPs and help in the movement of Rho GTPases between the phospholipid 
membrane and the cytosol (Hanna et al., 2013).   
 The three most studied members of the Rho family are Rho, Rac, and Cdc42 
(Reymond et al., 2011). RhoA, Rac and Cdc42 play an essential function in the actin 
dynamics necessary for cancer cell motility (El Sibai et al., 2007).  Each of them have 
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a defined role in actin nucleation and polymerization, adhesions formation, stress fiber 
assembly, and actomyosin contractility. However, a continuous crosstalk and 
interplay between these different members govern the regulation of the different 
aspects pertaining to the cell motility cycle. Dominant inhibition or activation of Rho 
GTPases or any of their downstream effectors can have large consequences on cancer 
cells motility, invasion, and metastasis (Hanna et al., 2014).    
 
Fig. 3. The Activation and deactivation cycle of Rho GTPases. Rho proteins cycle between two 
forms, the GTP- active form that can stimulate downstream reactions and the GDP-inactive form. 
Three proteins regulate the Rho proteins, GEF that can switch them to the active form, GAP that 
works opposite to GEF, and GDI that can hold both the active and inactive forms away from their 
membrane binding sites stopping their function. (Aktories & Barbieri, 2005). 
 
1.4. Invadopdia 
1.4.1. Overview of Invadopodia 
 Remodeling of the actin cytoskeleton, and formation of actin-based 
protrusions are examples of the several events that allow cell movement, nutrients 
search, and wound healing etc. These structures are essential for both appropriate 
attachment to the extracellular matrix and distinguishing the adjacent matrix for 
growth factors (Hall, 2009).  
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 They can be categorized into two groups, the first group resulting in 2D 
movement includes actin formations such as lamellipodia and filopodia, and the 
second in motility in the third dimension relying on other different actin formations. 
Several features differentiate between them such as cellular localization, protrusion 
capacity, length of formation time, proteins involved, and role in the cell (Murphy & 
Courtneidge, 2011). Podosomes and invadopodia are the major structures to be 
recognized in the specific case of 3D locomotion. Several references group them as 
two arrangements of one phenotype, but others distinguish between them with respect 
to length of action and the capability to activate metalloproteases (Chen et al., 1989). 
 In an attempt to simplify the misperception between both terms (podosomes 
and invadopodia), the following was suggested: The use of the term podosome refers 
to normal cell types whereas invadopodia would point to cancerous cells (Murphy & 
Courtneidge, 2011). 
 
1.4.2. Invadopodia components and assembly 
 Metalloprotease activity, though not restricted to invadopodia, is a key factor 
in its structure assembly which can be viewed after staining with rhodamine-
phalloidin (Wang & McNiven, 2012). 
 Also playing a role in the regulation of invadopodia assembly is PKC and Src 
working together. 
 Phorbol ester stimulation will lead to the induction of PKC α through 
AFAP110 localizing with and activating Src, through a mechanism that requires PI3K 
activity (Tatin et al., 2006; Gatesman et al., 2004). This means that, PKC-Src-
dependent mechanism tend to regulate the establishment of podosomes and 
invadopodia. 
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1.4.3. Stage 1: Polarization and SRC Signaling 
 The cell has to switch from an inactive to a moving stage to initiate the 
assembly of invadopodia. At that stage the attachments at the leading edge disappear 
and the arrangement of invadopodia begins (Block et al., 2008). 
FAK, being accountable for the construction and termination of focal adhesions, is 
not only thought to control the initiation of invadopodia but it is also known to 
influence Src kinase (Wang & McNiven, 2012). It has been defined to negatively 
affect invadopodia based on the spatial regulation of Src (Chan et al., 2009). 
 Based on the previous data the following model is suggested: The upregulation 
of focal adhesions will be signaled by the cell when it is in the quiescent stage. This 
will occur through the stimulation of FAK by its phosphorylation at the Y397 residue; 
which will end up in FAK binding to Src. The phosphorylation of Src at Y416 
mediated by FAK will activate its nearby focal adhesion spots (Tomar & Schlaepfer, 
2009). 
 The decrease of FAK in the cell will lead to the shift of Src from FAs to 
invadopodia. It is connected to the change the cell will undertake from the inactive to 
invasive stage (Chan et al., 2009). 
 
1.4.4. Stage 2: Invadopodia assembly and phosphoinositide3-kinase signaling 
 Initiation of invadopodia formation has been related to PI3K activation. The 
reduction in invadopodia formation and ECM degradation was previously shown to 
be accommodated with the use of PI3K inhibitors (Hoshino et al., 2012; Yamaguchi 
et al., 2011). Class I PI3K phosphorylates PIP(3.4)2 to produce PIP3. In addition to 
that, PIP3 will recruit kinases associated in invadopodia process, such as Akt serine 
threonine kinases and phosphoinositide-dependent protein kinase 1 (PDK1) (Cantley, 
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2002; Yamaguchi et al., 2011). Besides activating these kinases, PIP3 has a role as a 
lipid source for PIP(3.4)2 , which is associated in the presence of invadopodia in Src-
transformed fibroblasts (Oikawa et al., 2008). 
 Moreover, the scaffold protein Tks5 is recruited by PIP(3.4)2 through binding 
to its PX domain, which will guide it for colocalization along with cortactin at the cell 
phospholipid membrane (Clark & Weaver, 2008). Afterwards, Tks5 will bind to 
important actin regulators such as Nck1, Nck2, NWASP, and Grb2, via its SH3 
domain, leading to the control of invadopodia formation (Oikawa et al., 2008; Stylli 
et al., 2009). 
 Cortactin is another key element in the regulation of invadopodia in the Src 
pathway. A previous study dated from 1991 proves that cortactin being neutralized 
via antibodies will result in the formation of immature invadopodia, which do not 
have the capacity to degrade the ECM (Bowden et al., 1999). Newer studies highlight 
the contribution of cortactin in controlling the number and active status of podosomes 
and invadopodia (Magalhaes et al., 2011; Oser et al., 2010). Specifically, the role of 
cortactin will aid in the formation of invadopodia through either allowing actin 
organization at the invading location or directing ECM metalloproteinases. 
 
1.4.5. Stage 3: Invadopodia turnover and dissolution 
 The turnover of invadopodia has not been fully discovered, but its length has 
been approximated from minutes to hours (Murphy & Courtneidge, 2011). The ring 
structure is thought to be dissociated from the rest of the actin cytoskeleton and 
degraded partly. The actin head will dissolve first followed by the filamentous tail, a 
process that could take hours (Baldassarre et al., 2006). Protein phosphorylation is 
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crucial for both invadopodia turnover and formation. On the other hand, tyrosine 
phosphorylation of cortactin and AFAP110 is essential for invadopodia turnover. 
 Since the composition of lamellipodia, invadopodia, podosomes, filopodia and 
FAs is similar, it is likely that these formations alternate, work simultaneously, or 
even join to form a common formation termed “invadosome” or “invadotron” 
(McNiven, 2013). 
 
1.4.6. Role of Podosomes and Invadopodia in Cell Motility 
 The ability of the cell to move and invade requires the formation of attachment 
structures. This explains why cells with a lower number of adhesions move much 
slower than their counterparts with more adhesion formations (Luo et al., 2005).  
 The lipid bilayer of motile cells showing protrusions and invaginations will 
result in the arrangement of formations such as podosomes and invadopodia. A similar 
concept between them is present due to the high resemblance in appearance, in 
addition to common architectural features and functions (Buccione et al., 2004). 
 Originally observed in cells transformed by the Rous sarcoma virus, and in 
monocyte-derived cells with the examples of macrophages and osteoclasts, 
podosomes were known to possess highly dynamic contact sites (David-Pfeuty et al., 
1980). 
 These initially termed rosettes have a center formed of actin complexes and 
bounded by a ring of proteins such as α-actinin, vinculin, talin, Src, and tyrosine-
phosphorylated proteins (Linder et al., 2003). 
 Gelsolin, cortactin, dynamin, WASP/NWASP, and Arp2/3 are proteins which 
regulate actin polymerization and which go together with the previously mentioned 
rosettes. Their role is still unknown, yet they serve as focal adhesions and comprise 
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metalloproteases, which may play a role in matrix degradation at their formation sites 
(Niiya et al., 2009). 
Polarizing myeloid cells and initiating podosomes require soluble factors with the 
example of chemotactic or growth factor functioning through serpentine and receptor 
tyrosine kinases (Monypenny et al., 2011). 
 Previous experiments proved that WASP and WIP are essential for actin 
polymerization and protrusion arrangement, formation of podosome centers, as well 
as for the action of integrins and integrin-linked proteins (Calle et al., 2008). 
Simultaneously podosome formation seem to be regulated by WASPs, in addition to 
podosome disassembly which is led by an open conformation of WASP (Dovas et al., 
2009). 
Moreover, invadopodia are characterized by convoluting changes in the inner layer of 
plasma membrane of invading cancer cells resembling the ones specific to 
podosomes. 
They are also induced by Rous sarcoma virus-transformed chicken embryonic 
fibroblasts (Bowden et al, 1999). 
 Similar to podosomes, the formation of invadopodia is controlled by actin 
cytoskeleton regulatory proteins, such as cortactin, cofilin, Mena, fascin, formin, N-
WASP, and Arp2/3 complex (Yamaguchi et al., 2005).  
Furthermore, the cancer cells ability to form invadopodia is considered a marker of 
their capacity to metastasize and digest the surrounding matrix. 
 On the other hand, invadopodia formation involves the contribution of 
oncogenic growth factor receptors and signaling proteins, such as EGF receptor, 
PDGF receptor, Met, Abl, Src, and phosphoinositide 3-kinase p110alpha (Yamaguchi 
et al., 2011). 
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 Unlike, podosomes which are present in non-cancerous; invadopodia are 
present in cancerous invasive cells and in transformed fibroblasts (García et al., 2012). 
 
Fig. 4. Tumor cell invasive types. The three types are plasma membrane blebs, invadopodia or 
pseudopodia. Protruding blebs totally lack actin, invadopodia are rich in actin and proteins that 
regulate actin, as for pseudopodia it depends on Wave protein to nucleate actin (Nürnberg, Kitzing & 
Grosse, 2011). 
 
 
1.5. Palladin 
1.5.1. Palladin Isoforms and Relatives 
 Palladin is a newly studied actin-linked protein, with a full length of 90-kDa. 
It is known to localize to actin-rich formations for their establishment and 
maintenance in different cell lines (Parast et al., 2000). Vertebrates were found to 
highly express the protein palladin which was considered abundant and ubiquitous in 
both embryonic and adult mouse tissues. It has three Ig-domains, and is therefore 
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considered as a novel part of a family of cellular proteins localized in the cytoplasm 
(Rachlin et al., 2006). 
 Myopalladin and myotilin are considered the two relatives of palladin. They 
all have several copies of a unique Ig-like domain (Bang et al., 2001). 
 Palladin co-localizing with α-actinin in focal adhesions, Z-lines, stress fibers 
and cell–cell junctions implied that myopalladin and palladin have mutual roles in 
stress fiber and Z-line formation and regulation (Salmikangas et al., 2003). 
 Myotilin, acting as an F-actin-binding protein, has a main role in controlling 
actin dynamics, forming actin-based arrays and is also needed for crosslinking 
bundles of F-actin (Dixon et al., 2008). This implied that palladin may also have a 
role as an F-actin-binding protein. 
 The interaction of palladin with different actin binding proteins validated its 
function as a cytoskeleton scaffolding molecule without restricting it to being an actin-
crosslinking protein only (Boukhelifa et al., 2006).  
 In addition to that palladin interacts with the proline-rich region of profilin, 
which functions in actin dynamics. The function and localization of Profilin is 
regulated by protein complexes such as ARP2/3, WASP/WAVE/Scar, and VASP 
(Boukhelifa et al., 2004). 
 Stimulation with PDGF and phorbol ester leads to the binding of palladin and 
Eps8, which triggers the assembly of dorsal ruffles and podosomes (Goicoechea et al., 
2006).  
 Lasp-1 protein, known to function in cytoskeletal organization, was also 
recognized to interact with palladin. Their co-localization had an impact on actin 
polymerization and on the formation of bundles of actin filaments (Rachlin et al., 
2006). 
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 The binding between palladin and Src will result in an interaction that 
regulates the formation of podosomes adding to the variety of palladin binding 
proteins (Rönty et al., 2007). 
 
1.5.2. Role of Palladin in Cell Motility 
 Previous studies designated that palladin plays a specific role in the 
rearrangement of actin cytoskeleton which is needed for both cell motility and cellular 
contractility.  
The regulation of actin cytoskeleton was previously shown to be dependent on cell 
motility. In the same token, palladin had a role in regulating cell movement through 
the establishment of cellular adhesions along with the conservation of cell 
morphology specifically in trophoblast and fibroblast cells (Parast et al., 2000). 
 The upregulation of the palladin expression in COS-7 cells, resulted not only 
in actin bundling but also in the overexpression of the 90-kDa and 140-kDa isoforms 
which ended up in the development of strong actin bundles and the assembly of star-
shaped F-actin arrays, respectively (Rönty et al., 2007). 
 
1.5.3. Role of Palladin in Invasion through Podosomes and Invadopodia 
Formation 
 A suggested hypothesis that palladin could be participating in the invasiveness 
of cancer cells with metastatic potential is due to its critical function in the regulation 
of actin cytoskeleton, cell attachment, and cell movement (García et al., 2012).  
 In breast cancer patients, malignant tissues showed higher levels of palladin 
expression with respect to normal breast samples. It seemed that breast cell types with 
a high invasion potential, such as BT549, MDA-MB-231, SUM159 and Hs 578, have 
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a higher level of expression of palladin than non-invasive, MCF7, BT474, ZR75.1, 
and T49D breast cancer cells (Goicoechea et al., 2008).  
 Previous studies showed that overexpressing palladin in breast cancer cell 
lines of a mouse host is accountable for the migration and invasion potentials of breast 
cancer cells (Wang et al., 2004). 
Further experiments showed that PDBu treated - invasive breast cancer cells 
witnessed a major decrease in podosome formation upon the knockdown of the 
palladin protein (Goicoechea et al., 2008). 
The formation of invadopodia in CAFs expressing the palladin protein was regulated 
by Protein Kinase C (PKC), as it was recognized that palladin is responsible for the 
stimulation of podosomes and invadopodia formation in numerous other cancer cells 
(Hai, 2002).  
 Moreover, phorbol ester stimulation using PMA prompted invadopodia 
formation in carcinoma associated fibroblasts (CAFs). These invadopodias were 
shown to contain palladin, which was responsible for matrix digestion and 
invasiveness, both in vivo and in vitro of pancreatic cancer cells (Goicoechea et al., 
2013). 
 These findings validated that palladin regulates both cell adhesion and 2D 
motility along with 3D cell motility of invasive cell lines. 
 
1.5.4 Palladin and Rho GTPases 
 Recent studies established that palladin plays a fundemental role in the 
activation of Rho GTPases, signifying that this link contributed to the formation of 
podosomes and invadopodia.  
It was previously established that the binding of palladin to Eps8 enhances podosome 
formation in vascular smooth muscle cells. Given that Eps8 was stated to contribute 
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in influencing the activity of Rac, it was verified whether palladin had also a role in 
this pathway. It was shown that palladin knockdown in HeLa cells resulted in a drop 
in the levels of active Rac, implying a vital role in Rac activation through the 
interaction between palladin and Eps8 (Goicoechea et al., 2006). 
 Another more recent set of experiments questioned whether Cdc42 has a role 
in PMA-induced cell with respect to invadopodia formation and whether palladin 
controls the activity of Cdc42 in cancer-associated fibroblasts (CAFs). The role of 
Cdc42 was confirmed with respect to the formation of invadopodia in CAFs given 
that it was previously linked to its formation in smooth muscle cells, human melanoma 
cells and metastatic rat carcinoma mammary cells.  
 Results showed that invadopodia formation was absent in Cdc42-knockdown 
cells treated with PMA showing that active Cdc42 is vital for the assembly of 
invadopodia and consequently cell invasion. In addition to that palladin expression 
was knocked down to check whether palladin plays a role in the activity of Cdc42. 
 This resulted in a significant drop in the activity of Cdc42 when palladin 
expression is absent. The previous data sums up that palladin is essential for the 
activation of Cdc42, which is needed for the formation of invadopodia and invasive 
profile of the cells (Goicoechea et al., 2013). 
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1.6. Purpose of the Study 
 Our first aim in this study is to look at the role of RhoC and Cdc42 in 
invadopodia formation.  
The second aim is to determine the crosstalk between RhoC and Cdc42 as mediated 
by the protein ROCK during invadopodia formation. 
The third aim is to look at the in vitro effect of cell-free palladin on cell motility and 
invasion of different breast cancer cell types. 
Finally, we want to study the crosstalk between several Rho-GTPases and the paladin 
protein relating these pathways to different markers of cell motility.  
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Chapter 2 
 
Materials and Methods 
 
2.1. Cell culture 
 Two human breast cancer cell lines (MCF-7 and MDA-MB231) obtained from 
ATCC (American Type Culture Collection), were cultured in DMEM medium 
supplemented with 10% FBS and 100U penicillin/streptomycin at 37°C and 5% CO2 
in a humidified chamber. Two human brain cancer cell lines (SF268 and Neuro-2A) 
obtained from ATCC (American Type Culture Collection), were cultured in DMEM 
medium supplemented with 10% FBS and 100U penicillin/streptomycin at 37°C and 
5% CO2 in a humidified chamber. 
2.2. Antibodies and Reagents 
 Goat polyclonal anti-Palladin antibody was obtained from Abcam. Rabbit 
monoclonal anti-actin, mouse monoclonal anti-NWASP, mouse monoclonal anti-
Cdc42, mouse monoclonal anti-Arp2/3, and mouse monoclonal anti-Cortactin 
antibodies were purchased from Santa Cruz Biotechnology. Anti-goat, anti-rabbit and 
anti-mouse HRP-conjugated secondary antibodies were obtained from Promega 
(Madison, WI, USA). Fluorescent secondary antibodies (Alexa Fluor 488) were 
obtained from Invitrogen. To visualize the actin cytoskeleton, cells were stained with 
Rhodamine phalloidin (Invitrogen). 
2.3. Cell transfection with siRNA 
 Goat FlexiTube siRNA for RhoA, siRNA for RhoC, siRNA for Cdc42, siRNA 
for palladin were obtained from Qiagen. The cells were transfected with the siRNA at 
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a final concentration of 10 nM using HiPerfect (Qiagen) as described by the 
manufacturer. Control cells were transfected with siRNA sequences targeting GL2 
Luciferase (Qiagen). After 72 hours, protein levels in total cell lysates were analyzed 
by western blotting using the appropriate antibodies or the effect of the corresponding 
knockdown was assayed. 
2.4. Western blotting 
 Cell lysates were prepared by scraping the cells in a sample buffer (4% SDS, 
10% β-mercaptoethanol, 20% glycerol, 0.004% bromophenol blue, and 0.125 M Tris- 
HCl at a pH of 6.8). The resulting lysates were boiled for 5 minutes. Protein samples 
were separated by SDS-PAGE on 10% gels and transferred to PVDF membranes for 
70 minutes at 100V. The membranes were then blocked with 5% BSA in PBS 
containing 0.1% Tween-20 for 1 hour at room temperature and incubated with primary 
antibody at a concentration of 1:100 overnight at 4°C. After the incubation with the 
primary antibody, the membranes were washed and incubated with secondary 
antibody at a concentration of 1:1000 for 1 hour at room temperature. The membranes 
were then washed, and the bands visualized by treating the membranes with western 
blotting chemiluminescent reagent ECL (Bio-Rad). The results were obtained on an 
X-ray film (Agfa Healthcare). The levels of protein expression were compared by 
densitometry using the ImageJ software. 
2.5. Motility assay/Analyzing 2D motility: 
 For motility analysis, images of cells moving randomly in serum were 
collected every 60 seconds for 2 hours using a 20X objective. For experiments, cells 
were starved in L15 media (GIBCO BRL) with 0.35% BSA for 3 hours. During 
imaging, the temperature was controlled using a Nikon heating stage which was set at 
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37°C. The medium was buffered using HEPES and overlaid with mineral oil. The 
speed of cell movement was quantified using the ROI tracker plugin in the ImageJ 
software, which was used to calculate the total distance travelled by individual cells. 
The speed is then calculated by dividing this distance by the time (120 minutes) and 
reported in μm/min. The speed of at least 15 cells for each condition was calculated. 
The net distance travelled by the cell was calculated by measuring the distance 
travelled between the first and the last frames. 
2.6. Immunostaining 
 The cells were plated on cover slips, starved overnight and treated with the 
phorbol ester PMA an hour before starting the experiment with a final concentration 
of 150nm/ml, and with the rock inhibitor y27632 thirty minutes before starting the 
experiment with a final concentration of 25µm/ml. Cells were fixed with 4% 
paraformaldehyde for 10 minutes, and permeabilized with 0.5% Triton-X100 for 10 
minutes. To decrease background fluorescence, cells were rinsed with 0.1 M glycine 
then incubated with 0.1 M glycine for 10 minutes. For blocking, cells were incubated 
4 times with 1% BSA, 1% FBS in PBS for 5 minutes. Samples were stained with 
primary antibodies for 2 hours and with fluorophore-conjugated secondary antibodies 
for 2 hours. Fluorescent images were taken using a 60X objective on a fluorescent 
microscope. 
2.7. Pull-down Assay 
 Cells were either transfected with siRhoA or siRhoC construct or with 
siLuciferase construct as a control. Following treatment period, cells were lysed and 
the pull-down assay performed using the RhoA/Rac1/Cdc42 Activation Assay Combo 
Kit (Cell BioLabs) following the manufacturer’s instructions. Briefly, cell lysates 
were incubated with GST-RBD (for RhoA) or GST-PAK (for Rac1/Cdc42) for 1 h at 
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4˚C with gentle agitation. Then, the samples were centrifuged, and the pellet washed 
for several times. After the last wash, the pellets were resuspended with sample buffer 
and boiled for 5 min. GTP-RhoA and GTP-Rac1/Cdc42 were detected by western 
blotting using anti-RhoA, anti-Rac1 and anti-Cdc42 antibodies provided in the kit. 
Total proteins were collected prior to the incubation with GST beads and used as a 
loading control. 
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Chapter 3 
 
Results 
 
 
3.1. RhoC knockdown decreases 2D cell migration 
 In order to study the role of RhoC in 2D cell motility, we first looked at the 
level of RhoC protein expression before and after knockdown using siRNA 
transfection. Performing time-lapse microscopy showed that RhoC knockdown 
decreases cell motility.  
 
 
 
A.   
B.  
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C.  
Fig. 5. RhoC knockdown. Depletion of RhoC after 72 hours transfection with RhoC siRNA (A). 
RhoC positively regulates 2D cell motility. Knockdown of RhoC decreased cell motility when 
compared to control cells (B,C). Image j software was used to quantitate cell movement. Tracking 
was done over 120 frames, looking at 11 cells in each time-lapse movie, and the average distance was 
reported. Data are the mean -/+ SEM from 3 different experiments. The results were significant with 
p<0.001. 
 
3.2. RhoC increases 3D cell motility 
 After showing the role of RhoC in 2D cell motility, we wanted to check its 
effect on cell invasion (figure 6). The experiment consists of knocking down RhoC 
followed by starving and plating the cells in a boyden chamber, where they invade 
toward media rich in growth factors. The invading cells are trapped in the pores then 
stained, extracted and absorbance measured at 560 nm. RhoC seems to increase cell 
invasion since knocking down RhoC led to a decrease in the level of invasion. 
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Fig. 6. RhoC positively regulates 3D cell motility. Knockdown of RhoC decreased cell invasion as 
compared to control cells. Data are the mean -/+ SEM from 3 different experiments. The results were 
significant with p<0.001. 
 
 
3.3. 2D cell motility is Cdc42 independent  
 To be able to study the role of Cdc42 in cell pathways, Cdc42 knockdown was 
performed using two distinct oligos in order to decrease the protein expression levels. 
Cdc42 knockdown did not affect 2D cell motility as studied by time-lapse microscopy. 
Quantitation of cell movement was done using image j software where every cell was 
tracked over the 120 frames, 11 cells for each time-lapse movie, and the average of 
the distance was measured (figure 7). 
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A.
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B.  
Fig. 7. Cdc42 knockdown using siRNA oligos 4 and 7. Expression levels of Cdc42 were lowered 
by around 0.02 fold with oligo 7 in contrast to a 0.75 fold decrease with oligo4. Thus, siCdc42 oligo 
4 was used for further experimentation. The results were significant with p<0.001 (A). Cdc42 has no 
effect on 2D cell motility. Cells did not exhibit any change in 2D motility upon Cdc42 KD. Control 
and knock down phenotypes have approximately the same speed (Control (Luc): 0.0265 μm /min and 
KD: 0.0293 μm /min). The results were significant with p<0.001 (B). 
 
3.4. Cdc42 increases 3D cell motility 
 After showing that Cdc42 does not have a role in 2D cell motility, we wanted 
to check its effect on cell invasion (figure 8). The experiment consists of knocking 
down Cdc42 followed by starving and plating the cells in a boyden chamber, where 
they invade toward media rich in growth factors. The invading cells are trapped in the 
pores then stained, extracted and absorbance measured at 560 nm. Cdc42 seems to 
increase cell invasion since knocking down Cdc42 decreased the invasion level. 
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Fig. 8. Cdc42 positively regulates 3D cell motility. Knockdown of Cdc42 decreased cell invasion in 
contrast to control cells. Data are the mean -/+ SEM from 3 different experiments. The results were 
significant with p<0.001. 
 
3.5. Induction of invadopodia in breast cancer cells are Cdc42 
dependent 
 In order to study the role of RhoC and Cdc42 in invadopodia formation, we 
must first induce the formation of invadopodia (Figure 9). Cells were starved 
overnight and stimulated with PMA for one hour. Actin was then stained with 
rhodamine phalloidin.  
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Fig. 9. Invadopodia formation. Invadopodia formation induced using the phorbol ester PMA 
followed by actin staining via rhodamine phalloidin  
 
We also wanted to test the effect of Cdc42 on invadopodia formation so the 
protein was knocked down using siCdc42 (Figure 10). Cells were also starved 
overnight and stimulated with PMA for one hour. Then actin was stained with 
rhodamine phalloidin. Invadopodia formation was shown to be Cdc42 dependent. 
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Fig. 10. Invadopodia formation is Cdc42 dependent. The invadopodia structures were not present 
when the cells were transfected with siCdc42 also followed by acting staining with rhodamine 
phalloidin. 
 
3.6. Crosstalk between RhoA and Cdc42 
 In order to elucidate any potential signaling relationship between Cdc42, 
RhoA and RhoC, RhoA was knocked down using siRhoA (Figure 11-A), followed by 
a pulldown assay to check for the active levels of Cdc42 (Figure 11-B). Similarly, 
RhoC was knocked down using siRhoC (Figure 11-C), followed by a pulldown assay 
to check for the active levels of Cdc42 (Figure 11-D). RhoA was shown to increase 
the activation of Cdc42 whereas RhoC was shown to decrease the activation of Cdc42. 
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A.  
B.  
34 
 
C.  
D.  
Fig. 11. The effect of RhoA and RhoC on the expression level of active Cdc42. The 
activation levels of Cdc42 were assessed after RhoA knockdown, 0.75 fold decrease in 
RhoA protein expression (A). Upon RhoA depletion, decreased activation levels of Cdc42 
(active Cdc42) compared to the total level Cdc42 upon RhoA knock down and a 
quantification graph of the western blot bands showing a decrease in Cdc42 activation 
levels by 0.55 fold upon RhoA knock down (B). RhoC knockdown showed a 0.9 fold 
decrease in RhoC protein expression (C). Western blot bands showing the increased 
activation levels of Cdc42 (active Cdc42) compared to the total levels of Cdc42 upon RhoC 
knockdown and a quantification graph of the western blot bands showing an increase in 
Cdc42 activation levels by 0.2 fold upon RhoC knockdown (D). The results were significant 
with p<0.001. 
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3.7. ROCK inhibition leads to the increase in invadopodia formation 
 We wanted to check if RhoC is downregulating Cdc42 activation levels 
through ROCK, to do so we inhibited ROCK using Y27632 and checked for 
podosome formation (Figure 12). Cells treated with the ROCK inhibitor (Y27632) not 
only showed a higher number of podosomes, but also a higher percentage of cells with 
podosome formation. 
 
Fig. 12. Formation of invadopodia increases upon the inhibition of ROCK. The results 
were significant with p<0.001. 
 
3.8. Cdc42 colocalizes with actin structures 
 Knowing that invadopodia formation is correlated with the presence of 
dynamic actin structures we wanted to see the localization of Cdc42 with respect to 
the actin structures. This is achieved through co-immunostaining for both actin and 
Cdc42 (Figure 13). Cdc42 was shown to co-localize with actin structures inside the 
cell. 
36 
 
 
Fig. 13. Cdc42 colocalizes around actin structures in the cell. Cells stained with 
rhodamine phalloidin and anti-Cdc42 antibody tagged with a fluorophore showed that 
Cdc42 colocalizes with actin structures inside the cell. 
 
3.9. Y27632-mediated invadopodia are Cdc42-dependent 
 We have found that RhoC decreases the level of expression of active Cdc42. 
In addition to that, invadopodia formation was shown to be Cdc42 dependent. To 
check if RhoC is affecting Cdc42 through ROCK, we knocked down Cdc42 using 
siCdc42 and checked for the formation of invadopodia through staining for its 
markers, after treating the cells with the ROCK inhibitor Y27632 (Figure 14). 
Invadopodia was not formed in cells transfected with siCdc42 even in the condition 
of Y27632 treatment; however, cells that were not transfected with siCdc42, 
invadopodia did form upon treatment with Y27632. 
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Fig. 14. The effect of Cdc42 knockdown on Y27632 treated cells with respect to 
invadopodia formation. Invadopodia was not formed in cells transfected with siCdc42 
even in the condition of Y27632 treatment; however, cells that were not transfected with 
siCdc42, invadopodia did form upon treatment with Y27632. The results were significant 
with p<0.001. 
 
3.10. Y27632-mediated podosomes are Rac-independent 
 To further elucidate the crosstalk between Rho GTPases and invadopodia 
formation, the following experiment was conducted. The cells were transfected with 
siRac and then treated with Y27632 to check the effect of Rac on invadopodia 
formation (Figure 15). Knockdown of Rac showed no effect on invadopodia 
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formation on cells treated with Y27632 indicating that Rac does not play a role in 
invadopodia formation. 
 
 
Fig. 15. The effect of Rac knockdown on Y27632 treated cells with respect to 
invadopodia formation. Knockdown of Rac showed no effect on invadopodia formation on 
cells treated with Y27632 indicating that Rac does not play a role in invadopodia formation.  
 
3.11. Crosstalk between Palladin and Cdc42 
 In addition to all the previously established results, palladin was established 
to influence the invasiveness of CAFs. Therefore, it is of interest to look at potential 
crosstalk between palladin and Cdc42. To do so palladin was knocked down using 
siPalladin (Figure 16-A). A pull down assay was later on performed to collect the 
active levels of Cdc42 which was later tested through a western blot to compare the 
active and total levels of Cdc42 (Figure 16-B). Pull down assays showed that after 
palladin knockdown, Cdc42 activation levels increase. 
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A.  
B.  
Fig. 16. The effect of Palladin on the expression level of active Cdc42. The levels of 
active Cdc42 were measured after palladin knockdown (A). Western blot bands showing the 
increased levels of active Cdc42 compared to total Cdc42 upon palladin knockdown and a 
quantification graph of the western blot bands showing an increase in Cdc42 activation 
levels by 0.5 fold upon palladin knock down (B). 
  
40 
 
Chapter 4 
 
Discussion 
 
 
It was previously shown that both RhoA and RhoC regulate cell migration 
(DesMarais et al., 2009). Previous publications from our lab have focused on the role 
of RhoA (Hanna & El-Sibai, 2013). Therefore, it became of interest to study the role 
of RhoC first on 2D cell motility, and second on 3D cell motility as in cell invasion. 
Our data showed that RhoC knockdown decreases cell migration, which is concordant 
with previous studies (Condeelis et al., 2001). The next step was to look at the effect 
of RhoC on 3D cell motility, and RhoC knockdown was shown to inhibit cell invasion. 
Therefore, RhoC is needed for cellular invasion, and these results are consistent with 
previous literature (Condeelis et al., 2001).  
Our next aim was to look, for the first time, at the role of Cdc42 in cell motility. 
Our results showed that Cdc42 knockdown did not elicit any change in cell migration 
phenotype. Thus, Cdc42 has no role in 2D cell motility. However, when we looked at 
the effect of Cdc42 on 3D cell motility, our data showed a decrease in cell invasion 
following Cdc42 knockdown. Consequently, Cdc42 expression regulates cell 
invasion.  
Both RhoC and Cdc42 were therefore shown to have a role in 3D cell motility. 
Additionally, RhoC was previously established to influence the formation of 
invadopodia. Therefore, our next aim was to look similarly at the role of Cdc42 in 
invadopodia formation. First, we needed to induce the formation of invadopodia, 
which was achieved through starving the cells overnight and stimulating with PMA 
41 
 
for one hour. Furthermore, our results showed that Cdc42 knockdown inhibited the 
formation of invadopodia, implying that PMA-mediated invadopodia are Cdc42 
dependent. 
It was known in the literature that RhoA and RhoC affect focal adhesions and 
invadopodia formation, respectively (Yan, Shen, & Zhu, 2010; Bravo-Cordero, et al., 
2011; MacGrath, & Koleske, 2011), and since our findings showed that Cdc42 is 
involved in invadopodia formation, we wanted, next, to elucidate any potential 
signaling relationship between Cdc42, RhoA and RhoC.  
Usually, in order to monitor the activation levels of Rho GTPases, pull down 
assays are performed. PAK1 PBD (p21 activating kinase p21 GTPase binding 
domain) are used to bind Rac and Cdc42 whereas RBD beads are used to bind Rho.  
RhoA knockdown followed by a pulldown assay was done to measure the 
activation levels of Cdc42. The activation levels of Cdc42 were shown to decrease 
after RhoA knockdown. Therefore, RhoA upregulates Cdc42 activation levels.  
Following the establishment of the effect of RhoA on Cdc42 expression levels, 
it became of interest to determine whether RhoC, in turn, affects Cdc42, knowing that 
both RhoC and Cdc42 are known to participate in cell invasion and invadopodia 
formation. Pulldown assays showed that RhoC knockdown led to an increase in Cdc42 
activation levels. Therefore, RhoC downregulates Cdc42 activation levels. 
We have found that active Cdc42 levels are increased by RhoA and decreased 
by RhoC. This is consistent with the CONDEELIS model in invadopodia, which 
describes invadopodia as an inner circle surrounded by a rim of proteins that function 
to inhibit invadopodia. This ultimately allows to concentrate the invadopodia 
structure, focusing it in the center. RhoA was showed to be active in the center leading 
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to activation of Cdc42 to concentrate the invadopodia, and RhoC is active around it, 
leading to activation of ROCK which inhibits Cdc42 to focus the invadopodia. 
Furthermore, Cdc42 is needed for the activation of WASP, Cofilin, formation of actin, 
and ultimately invadopodia formation (Condeelis et al., 2001). 
So far, we have shown that Cdc42 is needed for invadopodia, and a crosstalk 
exists between the Rho GTPases whereby RhoA upregulates Cdc42 activation levels, 
and RhoC downregulates Cdc42 activation levels, which is consistent with the 
previously described model (Condeelis et al., 2001). If this model is correct, then our 
next aim is to establish that the inhibition of Cdc42 by RhoC occurs through the action 
of ROCK. Therefore, we inhibited ROCK and looked at the formation of invadopodia. 
Our results showed that ROCK inhibition leads to the increase in invadopodia 
formation both in number and size, which implies that following ROCK inhibition, 
the invadopodia were no longer concentrated and focused centrally.  
Additionally, our data showed that Cdc42 colocalizes with the actin formation, 
and Cdc42 knockdown leads to the inhibition of the invadopodia mediated by ROCK 
inhibition, implying that these invadopodia formations are indeed Cdc42 dependent. 
Consequently, ROCK, downstream from RhoC, inhibits cdc42 to keep invadopodia 
focused. 
On the other hand, our results showed that the ROCK inhibitor – mediated 
invadopodia are Rac independent since knockdown of Rac does not affect the 
formation of invadopodia following ROCK inhibition. 
In addition, Palladin was established to be a part of the invasive potential of 
cancer associated fibroblasts, so it is of interest to look at any possible crosstalk 
between Palladin and Cdc42. Our data showed that following Palladin knockdown, 
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Cdc42 activation levels increase implying that Palladin downregulates Cdc42 
activation levels. Future work would therefore look at whether palladin is acting 
upstream from RhoC, possibly activating it, in order to exhibit the inhibitory effect on 
Cdc42. 
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Chapter 5 
 
Conclusion 
 
 
 
In this study, we looked at the crosstalk between RhoC and Cdc42 during 
invadopodia formation. Our results suggest that both RhoC and Cdc42 expression are 
necessary for invadopodia formation and that RhoC downregulates Cdc42 activation 
levels. Furthermore, our data shows that ROCK inhibition leads to the increase in 
invadopodia formation, which is no longer focused, and that this increase depends on 
Cdc42 expression. These results validate the previously established model of 
invadopodia, which describes the activation of RhoC at the edge of the invadopodia 
to focus it. Therefore, RhoC activates ROCK which inhibits Cdc42 to keep the 
invadopodia concentrated centrally. In addition, Palladin was shown to downregulate 
Cdc42 activation levels, and future work will look into whether Palladin leads to this 
inhibition of Cdc42 by acting upstream from RhoC. 
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